Nova Scotia urged to accelerate switch from Pap tests to HPV screening for cervical cancer

Following New Brunswick's decision to adopt HPV testing, Nova Scotia remains the last Atlantic province relying on Pap smears for cervical cancer screening. Opposition leaders and medical specialists are pressing the provincial government to provide a timeline for the transition, citing the province's high cervical cancer rates and an estimated $550,000 setup cost.

Nova Scotia is facing renewed pressure from opposition politicians and medical specialists to transition from traditional Pap smears to human papillomavirus (HPV) testing as its primary method for cervical cancer screening. The calls intensified after New Brunswick announced on Wednesday that it is making the switch, leaving Nova Scotia as the last Atlantic Canadian province still relying on Pap tests.

Editorial illustration

NDP Leader Claudia Chender urged the provincial government to adopt HPV screening, stating that women and gender-diverse Nova Scotians deserve better access to health care. Dr. Robert Grimshaw, a gynecologic cancer specialist, expressed deep disappointment at the delay in implementing the new testing method in the province.

According to data from the Canadian Partnership Against Cancer, Nova Scotia has the second-highest rate of cervical cancer in Canada, behind only Saskatchewan. Dr. Grimshaw noted that HPV testing is more effective, less invasive, and cost-efficient. He estimated the upfront cost for setting up the HPV program, including follow-up care using nurses, would be approximately $550,000.

The Department of Health and Wellness stated in July 2024 that work is underway to understand the requirements for the transition, including laboratory capacity, equipment, and follow-up care. However, officials did not provide a timeline for implementation.

Editorial illustration

Provinces that have already adopted HPV testing for primary cervical cancer screening include Prince Edward Island, British Columbia, Ontario, Alberta, Quebec, and now New Brunswick. HPV testing can be performed via at-home self-sampling kits, which are expected to be available in New Brunswick by next year. The recommended interval for HPV screening is every five years, compared to the three-year interval recommended for Pap testing.

The federal government has set a goal to eliminate cervical cancer as a public health problem by 2040.

Sources